It can be seen that after the insulin liposome INS/PFOB@LIP treatment, the symptoms of keratitis were alleviated, the INS/PFOB@LIP corneal epithelium was basically completely healed, and the new angiogenesis was the least, and compared with other experimental control groups, the INS/PFOB@LIP group had lower inflammatory factors than NS, PFOB@LIP, and INS groups, and the differences were statistically significant (P < 0.01), demonstrating that insulin liposomes can be used as potential therapeutics for corneal inflammation. Here, INS is linked to keratitis.